I don't really understand why anybody would invest in CYP, they have clearly lost the race to Mesoblast hands down.
I believe that stem cell technology will be the future of medicine and Mesoblast will have a major piece of that action, that is why I have a significant holding in MSB.
If you really want to diversify in the Stem Cell arena take a look at Reneuron (RENE on AIM). Loaded exosome technology as a delivery system across the blood brain barrier. They are inking JVs with US Biopharma and have a market cap of just 42 million GBP.
I own shares in RENE but a much larger position in MSB.
I don't really understand why anybody would invest in CYP, they...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.020(1.73%) |
Mkt cap ! $1.341B | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.21 | $1.17 | $16.67M | 14.04M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 54704 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.19 |
Change
0.020 ( 3.40 %) |
||||
| Open | High | Low | Volume | ||
| $1.21 | $1.21 | $1.17 | 2927691 | ||
| Last updated 15.59pm 07/05/2024 ? | |||||
| MSB (ASX) Chart |